AFT Pharmaceuticals Limited (AFP.AX) Stock Analysis & Winston Score

AFT Pharmaceuticals is a New Zealand-based company that develops and sells prescription and over-the-counter medicines. Its products include pain relief, cold and flu treatments, and hospital medicines sold to pharmacies, hospitals, and healthcare providers. The company owns brands like Maxigesic, a combination painkiller it has licensed to partners in dozens of countries. AFT makes money by selling its own branded medicines directly in New Zealand and Australia, and by collecting licensing fees and royalties when overseas partners sell its products in their markets. It operates primarily across Australasia but has licensing deals spanning over 100 countries, giving it global reach without the cost of running foreign sales teams. Its main competitive advantage is its proprietary drug formulations and an expanding international licensing network, though a key risk is its reliance on a relatively small product portfolio, meaning any setback with a flagship product like Maxigesic could have an outsized impact on revenue.